Fortitude Family Office’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$440	Buy	+87	New	+$440	﹤0.01%	1865
2024 Q3	–	Sell	-81	Closed	-$608	–	1263
2024 Q2	$608	Buy	+81	New	+$608	﹤0.01%	914